128 related articles for article (PubMed ID: 11157494)
21. Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model.
Canale S; Cocco C; Frasson C; Seganfreddo E; Di Carlo E; Ognio E; Sorrentino C; Ribatti D; Zorzoli A; Basso G; Dufour C; Airoldi I
Leukemia; 2011 Dec; 25(12):1815-24. PubMed ID: 21701492
[TBL] [Abstract][Full Text] [Related]
22. Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence.
Wu S; Gessner R; von Stackelberg A; Kirchner R; Henze G; Seeger K
Cancer; 2005 Mar; 103(5):1054-63. PubMed ID: 15651075
[TBL] [Abstract][Full Text] [Related]
23. The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines.
Batova A; Shao LE; Diccianni MB; Yu AL; Tanaka T; Rephaeli A; Nudelman A; Yu J
Blood; 2002 Nov; 100(9):3319-24. PubMed ID: 12384433
[TBL] [Abstract][Full Text] [Related]
24. Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia.
Coustan-Smith E; Kitanaka A; Pui CH; McNinch L; Evans WE; Raimondi SC; Behm FG; Aricò M; Campana D
Blood; 1996 Feb; 87(3):1140-6. PubMed ID: 8562940
[TBL] [Abstract][Full Text] [Related]
25. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
26. Effect of myelopoietic and pleiotropic cytokines on colony formation by blast cells of children with acute lymphoblastic leukemia.
Benko I; Kovács P; Szegedi I; Megyeri A; Kiss A; Balogh E; Oláh E; Kappelmayer J; Kiss C
Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):499-508. PubMed ID: 11383710
[TBL] [Abstract][Full Text] [Related]
27. Proliferation of MIELIKI a novel t(7;9) early pre-B acute lymphoblastic leukemia cell line is inhibited concomitantly by IL-4 and IL-7.
Renard N; Duvert V; Matthews DJ; Pagés MP; Magaud JP; Manel AM; Pandrau-Garcia D; Philippe N; Banchereau J; Saeland S
Leukemia; 1995 Jul; 9(7):1219-26. PubMed ID: 7630198
[TBL] [Abstract][Full Text] [Related]
28. Effects of recombinant human IL-7 on blast cell proliferation in acute lymphoblastic leukemia.
Eder M; Ottmann OG; Hansen-Hagge TE; Bartram CR; Gillis S; Hoelzer D; Ganser A
Leukemia; 1990 Aug; 4(8):533-40. PubMed ID: 2388482
[TBL] [Abstract][Full Text] [Related]
29. Interleukin 4 inhibits the proliferation and promotes the maturation of human leukemic early B cells.
Ouaaz F; Mentz F; Mossalayi MD; Schmitt C; Michel A; Debre P; Guillosson JJ; Merle-Beral H; Arock M
Eur J Haematol; 1993 Nov; 51(5):276-81. PubMed ID: 8282088
[TBL] [Abstract][Full Text] [Related]
30. Short-term liquid marrow cultures are supported by a mixture of haematopoietic cytokines but do not purge for acute myeloid or lymphoid leukemic marrow cells.
Johnsen HE; Gaarsdal E; Jensen L; Philip P; Hansen NE
Leukemia; 1993 Sep; 7(9):1402-8. PubMed ID: 8371591
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
[TBL] [Abstract][Full Text] [Related]
32. Migration of acute lymphoblastic leukemia cells into human bone marrow stroma.
Makrynikola V; Bianchi A; Bradstock K; Gottlieb D; Hewson J
Leukemia; 1994 Oct; 8(10):1734-43. PubMed ID: 7523799
[TBL] [Abstract][Full Text] [Related]
33. The role of interleukin-4 in the negative regulation of leukemia cell growth.
Akashi K
Leuk Lymphoma; 1993 Feb; 9(3):205-9. PubMed ID: 7682464
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with bcl-2 up-regulation, cortical/mature immunophenotype, and better early cytoreduction of childhood T-cell acute lymphoblastic leukemia.
Karawajew L; Ruppert V; Wuchter C; Kösser A; Schrappe M; Dörken B; Ludwig WD
Blood; 2000 Jul; 96(1):297-306. PubMed ID: 10891465
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-4 enhances the survival of severe combined immunodeficient mice engrafted with human B-cell precursor leukemia.
Mitchell PL; Clutterbuck RD; Powles RL; De Lord C; Morilla R; Hiorns LR; Titley J; Catovsky D; Millar JL
Blood; 1996 Jun; 87(11):4797-803. PubMed ID: 8639851
[TBL] [Abstract][Full Text] [Related]
36. Stromal cell-mediated transcriptional regulation of the CD13/aminopeptidase N gene in leukemic cells.
Saito M; Kumagai M; Okazaki T; Nakazawa S; Shapiro LH; Look AT; Campana D
Leukemia; 1995 Sep; 9(9):1508-16. PubMed ID: 7658720
[TBL] [Abstract][Full Text] [Related]
37. Applications of cytometry to study acute leukemia: in vitro determination of drug sensitivity and detection of minimal residual disease.
Campana D
Cytometry; 1994 Jun; 18(2):68-74. PubMed ID: 7924700
[TBL] [Abstract][Full Text] [Related]
38. Effects of IL-7 on human lymphocytes.
Kim HS; Kang CM; Findley H; Ragab AH
J Korean Med Sci; 1993 Apr; 8(2):93-8. PubMed ID: 8397935
[TBL] [Abstract][Full Text] [Related]
39. Effects of recombinant human cytokines on precursor-B acute lymphoblastic leukemia cells.
Makrynikola V; Kabral A; Bradstock KF
Exp Hematol; 1991 Aug; 19(7):674-9. PubMed ID: 1893954
[TBL] [Abstract][Full Text] [Related]
40. The growth of highly proliferative acute lymphoblastic leukemia may be independent of stroma and/or angiogenesis.
Schneider P; Vasse M; Sbaa-Ketata E; Lenormand B; Hong L; Soria C; Vannier JP
Leukemia; 2001 Jul; 15(7):1143-5. PubMed ID: 11455989
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
